Long-term efficacy, safety, and patient acceptability of ibandronate in the treatment of postmenopausal osteoporosis

Several second-generation bisphosphonates (BPs) are approved in osteoporosis treatment. Efficacy and safety depends on potency of farnesyl pyrophosphate synthase (FPPS) inhibition, hydroxyapatite affinity, compliance and adherence. The latter may be influenced by frequency and route of administratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Inderjeeth, Charles A, Glendenning, Paul, Ratnagobal, Shoba, Inderjeeth, Diren Che, Ondhia, Chandni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274146/
https://www.ncbi.nlm.nih.gov/pubmed/25565901
http://dx.doi.org/10.2147/IJWH.S73944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274146/
https://www.ncbi.nlm.nih.gov/pubmed/25565901
http://dx.doi.org/10.2147/IJWH.S73944

Ejemplares similares